SLC6A3 and Parkinson disease: To define the levels of several key protein markers of PD pathology, quantitative immunoblotting was performed for levels of α-synuclein, p62, TH, and DAT in the striatum (Figures 3A–3D and S3A) and midbrain (Figures 3E–3G and S4A).